Healthcare Services

Global Gastric Cancer Market to Reach $7.28B by 2030 at 14.8% CAGR

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Gastric Cancer Market Between 2026 And 2030?

The gastric cancer market has experienced swift growth in recent years. It is projected to expand from $3.64 billion in 2025 to $4.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.2%. This growth observed in the historic period can be attributed to factors such as the high prevalence of helicobacter pylori infection, smoking and dietary risk factors, the expansion of chemotherapy usage, the growth of hospital-based oncology care, and the development of surgical oncology.

The gastric cancer market is projected to experience substantial expansion over the coming years. It is anticipated to reach $7.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. This projected growth during the forecast period can be linked to several factors, including breakthroughs in immuno-oncology, the expansion of precision diagnostics, the proliferation of cancer screening initiatives, an expanding elderly demographic, and the creation of innovative targeted medications. Key trends anticipated over the forecast timeframe encompass the increasing uptake of targeted therapies and immunotherapies, a heightened emphasis on early detection and screening, the broadening of personalized cancer treatment strategies, the expanding application of combination therapy protocols, and enhanced multidisciplinary approaches to cancer care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

What Major Factors Are Driving The Gastric Cancer Market Forward?

Increasing obesity rates are projected to boost the growth of the gastric cancer market moving forward. Obesity is a medical condition defined by excessive accumulation of body fat, often categorized by a body mass index (BMI) of 30 or higher, which can lead to various health issues. The escalation in obesity rates results from factors such as unhealthy diets, insufficient physical activity, inactive lifestyles, environmental factors, and genetic predispositions. Surplus body fat, particularly visceral fat surrounding the abdomen, is connected to an elevated risk of developing gastric cancer. This is because obesity initiates chronic inflammation and metabolic disturbances, both linked to cancer development, thus contributing to an increased need for gastric cancer treatment. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, disclosed that one in eight people worldwide now live with obesity, surpassing 1 billion individuals. Therefore, the growing prevalence of obesity is propelling the gastric cancer market.

What Are The Different Segment Types In The Gastric Cancer Market Segment Breakdown?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Which Trends Are Impacting The Progress Of The Gastric Cancer Market?

Leading companies within the gastric cancer market are directing their efforts toward developing cutting-edge solutions, such as companion diagnostic assays, to facilitate personalized therapeutic approaches. A companion diagnostic assay is a test utilized to identify patients most likely to benefit from a specific therapeutic treatment by detecting the presence of certain biomarkers. For instance, in October 2024, F. Hoffmann-La Roche Ltd., a pharmaceutical company based in Switzerland, announced the U.S. Food and Drug Administration (FDA) approval for its VENTANA CLDN18 (43-14A) RxDx Assay. This assay is recognized as the first immunohistochemistry (IHC) companion diagnostic developed for assessing CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. It identifies patients eligible for targeted treatment with VYLOY (zolbetuximab) by measuring CLDN18 protein variants, primarily CLDN18. 2. Utilizing the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, this test significantly advances personalized healthcare, thereby expanding the treatment options available for gastric and GEJ adenocarcinoma.

Who Are The Well-Known Companies In The Gastric Cancer Market?

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd

Get The Full Gastric Cancer Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

Which Region Has The Greatest Market Share In The Gastric Cancer Market?

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gastric Cancer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

Browse Through More Reports Similar to the Global Gastric Cancer Market 2026, By The Business Research Company

Esophageal Cancer Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Gastric Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Ulcers Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795